SE0103539D0 - New Use - Google Patents

New Use

Info

Publication number
SE0103539D0
SE0103539D0 SE0103539A SE0103539A SE0103539D0 SE 0103539 D0 SE0103539 D0 SE 0103539D0 SE 0103539 A SE0103539 A SE 0103539A SE 0103539 A SE0103539 A SE 0103539A SE 0103539 D0 SE0103539 D0 SE 0103539D0
Authority
SE
Sweden
Prior art keywords
new use
treatment
prophylaxis
indole
obesity
Prior art date
Application number
SE0103539A
Other languages
English (en)
Inventor
Patrizia Caldirola
Original Assignee
Biovitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovitrum Ab filed Critical Biovitrum Ab
Priority to SE0103539A priority Critical patent/SE0103539D0/sv
Publication of SE0103539D0 publication Critical patent/SE0103539D0/sv
Priority to DE60218194T priority patent/DE60218194T2/de
Priority to PCT/SE2002/001929 priority patent/WO2003035061A1/en
Priority to US10/277,299 priority patent/US20030139424A1/en
Priority to JP2003537628A priority patent/JP2005506368A/ja
Priority to EP02786300A priority patent/EP1438045B1/en
Priority to DK02786300T priority patent/DK1438045T3/da
Priority to PT02786300T priority patent/PT1438045E/pt
Priority to ES02786300T priority patent/ES2282495T3/es
Priority to AT02786300T priority patent/ATE353646T1/de
Priority to CY20071100610T priority patent/CY1106566T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
SE0103539A 2001-10-23 2001-10-23 New Use SE0103539D0 (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE0103539A SE0103539D0 (sv) 2001-10-23 2001-10-23 New Use
AT02786300T ATE353646T1 (de) 2001-10-23 2002-10-22 Verwendung von indol- und indolin-derivaten bei der behandlung von adipositas oder zur reduzierung der nahrungsaufnahme
JP2003537628A JP2005506368A (ja) 2001-10-23 2002-10-22 肥満の処置におけるまたは食物摂取の減少のためのインドールおよびインドリン誘導体の使用
PCT/SE2002/001929 WO2003035061A1 (en) 2001-10-23 2002-10-22 Use of indole and indoline derivatives in the treatment of obesity or for the reduction of food intake
US10/277,299 US20030139424A1 (en) 2001-10-23 2002-10-22 Use
DE60218194T DE60218194T2 (de) 2001-10-23 2002-10-22 Verwendung von indol- und indolin-derivaten bei der behandlung von adipositas oder zur reduzierung der nahrungsaufnahme
EP02786300A EP1438045B1 (en) 2001-10-23 2002-10-22 Use of indole and indoline derivatives in the treatment of obesity or for the reduction of food intake
DK02786300T DK1438045T3 (da) 2001-10-23 2002-10-22 Anvendelse af indol- og indolin-derivater ved behandling af obesitet eller til reduktion af födeindtag
PT02786300T PT1438045E (pt) 2001-10-23 2002-10-22 Utilização de derivados de indole e indolina para o tratamento da obesidade ou para a redução de ingestão de alimentos
ES02786300T ES2282495T3 (es) 2001-10-23 2002-10-22 Uso de derivados de indol e indolino en el tratamiento de la obesidad o para la reduccion de consumo de alimento.
CY20071100610T CY1106566T1 (el) 2001-10-23 2007-05-07 Χρηση ινδολικων και ινδολινικων παραγωγων στην αντιμετωπιση της παχυσαρκιας ή για την ελαττωση της προσληψης τροφης

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0103539A SE0103539D0 (sv) 2001-10-23 2001-10-23 New Use

Publications (1)

Publication Number Publication Date
SE0103539D0 true SE0103539D0 (sv) 2001-10-23

Family

ID=20285750

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0103539A SE0103539D0 (sv) 2001-10-23 2001-10-23 New Use

Country Status (2)

Country Link
US (1) US20030139424A1 (sv)
SE (1) SE0103539D0 (sv)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4576959A (en) * 1984-02-06 1986-03-18 Eli Lilly And Company 6-Substituted-4-dialkylaminotetrahydrobenz[c,d]indoles
US5245046A (en) * 1988-11-14 1993-09-14 The Upjohn Company α-amino-indole-3-acetic acids useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents
GB9820113D0 (en) * 1998-09-15 1998-11-11 Merck Sharp & Dohme Therapeutic agents
TWI222450B (en) * 1999-07-28 2004-10-21 Upjohn Co Oxazinocarbazoles for the treatment of CNS diseases

Also Published As

Publication number Publication date
US20030139424A1 (en) 2003-07-24

Similar Documents

Publication Publication Date Title
NO20050851L (no) Kaspase-inhibitorer og anvendelser derav
ATE384058T1 (de) Thiazolderivate
CY1109242T1 (el) Θεραπευτικοι παραγοντες χρησιμοι για θεραπεια πονου
JO2282B1 (en) Oxazole derivatives
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
MXPA05012061A (es) Preparacion y uso de derivados alquilarilo para el tratamiento de la obesidad.
JO2764B1 (en) Indole derivatives or benzimidazole derivatives to modify the enzyme AKP kinase
DE60140814D1 (de) N-phenyl-2-pyrimidine-amine derivatives
MXPA05009595A (es) Compuestos 7-amino-isoindolilo y sus usos farmaceuticos.
IS8485A (is) Notkun á setnum 2-amínótetralínum í fyrirbyggjandi meðferð á Parkinsons-veiki
TW200616953A (en) Indole, indazole or indoline derivatives
NO20082096L (no) Azaindol-2-karboksamidderivativer
DE60218194D1 (de) Verwendung von indol- und indolin-derivaten bei der behandlung von adipositas oder zur reduzierung der nahrungsaufnahme
ATE449776T1 (de) Pyrroloä2,3-cüpyridinderivate
CY1108808T1 (el) Ενωσεις μοτιλιδης
DE60232173D1 (de) Verwendung von sulfonamid-derivaten bei der behandlung von adipositas oder zur verringerung der nahrungsaufnahme
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
IL195016A0 (en) 1h-indol-5-yl-piperazin-1-yl-methanone derivatives
EA200501310A1 (ru) Производные бензолсульфонамидов, способ их получения и их применение для лечения боли
SE0002739D0 (sv) New use
SE0103539D0 (sv) New Use
HK1080768A1 (en) Use of epothilone derivatives for the treatment ofhyperparathyroidism
HRP20050281A2 (en) Use of 4-pyridylmethyl-phthalazine derivatives for the manufacture of a medicament for the treatment of myelodysplastic syndromes
ATE346080T1 (de) Steroid-verbindungen mit anti-tumoraler wirkung
EA200500903A1 (ru) Силиловые простые эфиры